130 related articles for article (PubMed ID: 29205162)
1. Multiparametric-MRI-Guided Biopsy in the Era of Precision Medicine.
Bergero MA; Martínez PF; Radtke JP; Hadaschik BA
Arch Esp Urol; 2017 Dec; 70(10):833-844. PubMed ID: 29205162
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of diagnostic accuracy comparing prostate cancer detection by transrectal ultrasound-guided biopsy versus magnetic resonance (MR) imaging with subsequent MR-guided biopsy in men without previous prostate biopsies.
Pokorny MR; de Rooij M; Duncan E; Schröder FH; Parkinson R; Barentsz JO; Thompson LC
Eur Urol; 2014 Jul; 66(1):22-9. PubMed ID: 24666839
[TBL] [Abstract][Full Text] [Related]
3. Value of Serial Multiparametric Magnetic Resonance Imaging and Magnetic Resonance Imaging-guided Biopsies in Men with Low-risk Prostate Cancer on Active Surveillance After 1 Yr Follow-up.
Hamoen EHJ; Hoeks CMA; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Bokhorst LP; Witjes JA; Rovers MM; Hulsbergen-van de Kaa CA; Barentsz JO
Eur Urol Focus; 2019 May; 5(3):407-415. PubMed ID: 29331622
[TBL] [Abstract][Full Text] [Related]
4. Comparing Three Different Techniques for Magnetic Resonance Imaging-targeted Prostate Biopsies: A Systematic Review of In-bore versus Magnetic Resonance Imaging-transrectal Ultrasound fusion versus Cognitive Registration. Is There a Preferred Technique?
Wegelin O; van Melick HHE; Hooft L; Bosch JLHR; Reitsma HB; Barentsz JO; Somford DM
Eur Urol; 2017 Apr; 71(4):517-531. PubMed ID: 27568655
[TBL] [Abstract][Full Text] [Related]
5. Retrospective comparison of direct in-bore magnetic resonance imaging (MRI)-guided biopsy and fusion-guided biopsy in patients with MRI lesions which are likely or highly likely to be clinically significant prostate cancer.
Venderink W; van der Leest M; van Luijtelaar A; van de Ven WJM; Fütterer JJ; Sedelaar JPM; Huisman HJ
World J Urol; 2017 Dec; 35(12):1849-1855. PubMed ID: 28871396
[TBL] [Abstract][Full Text] [Related]
6. Magnetic resonance imaging-targeted biopsy may enhance the diagnostic accuracy of significant prostate cancer detection compared to standard transrectal ultrasound-guided biopsy: a systematic review and meta-analysis.
Schoots IG; Roobol MJ; Nieboer D; Bangma CH; Steyerberg EW; Hunink MG
Eur Urol; 2015 Sep; 68(3):438-50. PubMed ID: 25480312
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer detection in patients with prior negative biopsy undergoing cognitive-, robotic- or in-bore MRI target biopsy.
Kaufmann S; Russo GI; Bamberg F; Löwe L; Morgia G; Nikolaou K; Stenzl A; Kruck S; Bedke J
World J Urol; 2018 May; 36(5):761-768. PubMed ID: 29380130
[TBL] [Abstract][Full Text] [Related]
8. Multiparametric magnetic resonance imaging of the prostate can improve the predictive value of the urinary prostate cancer antigen 3 test in patients with elevated prostate-specific antigen levels and a previous negative biopsy.
Sciarra A; Panebianco V; Cattarino S; Busetto GM; De Berardinis E; Ciccariello M; Gentile V; Salciccia S
BJU Int; 2012 Dec; 110(11):1661-5. PubMed ID: 22564540
[TBL] [Abstract][Full Text] [Related]
9. MRI-guided biopsy of the prostate: correlation between the cancer detection rate and the number of previous negative TRUS biopsies.
Durmuş T; Reichelt U; Huppertz A; Hamm B; Beyersdorff D; Franiel T
Diagn Interv Radiol; 2013; 19(5):411-7. PubMed ID: 23886937
[TBL] [Abstract][Full Text] [Related]
10. A Prospective Comparison of Selective Multiparametric Magnetic Resonance Imaging Fusion-Targeted and Systematic Transrectal Ultrasound-Guided Biopsies for Detecting Prostate Cancer in Men Undergoing Repeated Biopsies.
Boesen L; Nørgaard N; Løgager V; Balslev I; Thomsen HS
Urol Int; 2017; 99(4):384-391. PubMed ID: 28651247
[TBL] [Abstract][Full Text] [Related]
11. Value of 3-T multiparametric magnetic resonance imaging and magnetic resonance-guided biopsy for early risk restratification in active surveillance of low-risk prostate cancer: a prospective multicenter cohort study.
Hoeks CM; Somford DM; van Oort IM; Vergunst H; Oddens JR; Smits GA; Roobol MJ; Bul M; Hambrock T; Witjes JA; Fütterer JJ; Hulsbergen-van de Kaa CA; Barentsz JO
Invest Radiol; 2014 Mar; 49(3):165-72. PubMed ID: 24220253
[TBL] [Abstract][Full Text] [Related]
12. Beyond transrectal ultrasound-guided prostate biopsies: available techniques and approaches.
Warlick C; Futterer J; Maruf M; George AK; Rastinehad AR; Pinto PA; Bosaily AE; Villers A; Moore CM; Mendhiratta N; Taneja SS; Ukimura O; Konety BR
World J Urol; 2019 Mar; 37(3):419-427. PubMed ID: 29943220
[TBL] [Abstract][Full Text] [Related]
13. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
14. High concordance of findings obtained from transgluteal magnetic resonance imaging - and transrectal ultrasonography-guided biopsy as compared with prostatectomy specimens.
Steurer S; Rico SD; Simon R; Minner S; Tsourlakis MC; Krech T; Koop C; Graefen M; Heinzer H; Adam M; Huland H; Schlomm T; Sauter G; Lumiani A
BJU Int; 2017 Sep; 120(3):365-376. PubMed ID: 28295933
[TBL] [Abstract][Full Text] [Related]
15. Improved detection of anterior fibromuscular stroma and transition zone prostate cancer using biparametric and multiparametric MRI with MRI-targeted biopsy and MRI-US fusion guidance.
Radtke JP; Boxler S; Kuru TH; Wolf MB; Alt CD; Popeneciu IV; Steinemann S; Huettenbrink C; Bergstraesser-Gasch C; Klein T; Kesch C; Roethke M; Becker N; Roth W; Schlemmer HP; Hohenfellner M; Hadaschik BA
Prostate Cancer Prostatic Dis; 2015 Sep; 18(3):288-96. PubMed ID: 26078202
[TBL] [Abstract][Full Text] [Related]
16. Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 3: Targeted Biopsy.
Venderink W; Bomers JG; Overduin CG; Padhani AR; de Lauw GR; Sedelaar MJ; Barentsz JO
Eur Urol; 2020 Apr; 77(4):481-490. PubMed ID: 31791623
[TBL] [Abstract][Full Text] [Related]
17. Cognitive MRI-TRUS fusion-targeted prostate biopsy according to PI-RADS classification in patients with prior negative systematic biopsy results.
Lai WJ; Wang HK; Liu HT; Park BK; Shen SH; Lin TP; Chung HJ; Huang YH; Chang YH
J Chin Med Assoc; 2016 Nov; 79(11):618-624. PubMed ID: 27567440
[TBL] [Abstract][Full Text] [Related]
18. Direct comparison of targeted MRI-guided biopsy with systematic transrectal ultrasound-guided biopsy in patients with previous negative prostate biopsies.
Kaufmann S; Kruck S; Kramer U; Gatidis S; Stenzl A; Roethke M; Scharpf M; Schilling D
Urol Int; 2015; 94(3):319-25. PubMed ID: 25227711
[TBL] [Abstract][Full Text] [Related]
19. Decision analysis model comparing cost of multiparametric magnetic resonance imaging vs. repeat biopsy for detection of prostate cancer in men with prior negative findings on biopsy.
Lotan Y; Haddad AQ; Costa DN; Pedrosa I; Rofsky NM; Roehrborn CG
Urol Oncol; 2015 Jun; 33(6):266.e9-16. PubMed ID: 25858102
[TBL] [Abstract][Full Text] [Related]
20. MRI/US fusion-guided prostate biopsy allows for equivalent cancer detection with significantly fewer needle cores in biopsy-naive men.
Yarlagadda VK; Lai WS; Gordetsky JB; Porter KK; Nix JW; Thomas JV; Rais-Bahrami S
Diagn Interv Radiol; 2018; 24(3):115-120. PubMed ID: 29770762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]